期刊文献+

A型肉毒毒素声带注射治疗内收型痉挛性发声障碍的剂量与疗效研究 被引量:2

Dosage of Botulinum Toxin Injection and the Duration of Curative Effect in the Treatment of Adductor Spasmodic Dysphonia
下载PDF
导出
摘要 目的探讨A型肉毒毒素声带注射治疗内收型痉挛性发声障碍的剂量和疗效维持时间。方法回顾性分析2003年9月至2017年10月间确诊并进行A型肉毒毒素声带注射治疗的79例内收型痉挛性发声障碍患者的临床资料,男11例,女68例,年龄17~75岁,平均31.56±11.16岁,病程1~16年,平均5.03±4.29年。记录注射日期、剂量、次数及疗效维持时间,对其中连续注射超过10次的12例患者,分析第1~10次注的平均注射剂量变化趋势及疗效维持时间。结果 79例患者首次注射剂量5~10u,平均6.28±1.57u,首次注射后疗效维持时间3~10月,平均4.53±1.62月。12例连续注射超过10次的患者每次注射剂量5~10u,平均5.83~8.54u,第1~10次注射剂量分别为5.83±1.63、8.43±2.20、7.75±1.72、8.12±1.55、8.54±1.28、7.92±1.79、8.02±1.25、7.92±1.79、7.29±1.67、7.19±1.69u;12例患者每次注射后疗效维持3~10月,1~10次平均维持时间分别为4.18±0.83、5.01±1.26、4.49±0.58、4.50±0.84、4.91±0.97、4.66±0.66、4.92±0.68、4.80±0.57、4.87±0.72、5.08±0.38月。结论 A型肉毒毒素单侧或双侧声带注射均能明显改善内收型痉挛性发声障碍患者的症状。本组连续注射10次以上的对象在第7次注射后平均注射剂量稳定于7~8u,平均疗效维持时间为4~6月。 Objective To study the dosage of the botulinum toxin type A injection and the duration of curative effect in the treatment of adductor spasmodic dysphonia.Methods The data of 79 patients received botulinum toxin type A treatmentfor adductor spasmodic dysphonia in Renmin Hospital of Wuhan University during September2003 to October 2017 were retrospectively studied.There were 11 men,68 women,aged from 17 to 75 years old with average of 31.56±11.16 years,the course of disease ranged from 1 to 16 years,and the average duration of disease was 5.03±4.29 years.Clinical data,injection date,dose,times and the duration of curative effectof each injection were all recorded.12 patients received at least 10 continuous injections.The mean dose of injections 1~10 was determined and the time-keeping of normal voice were also determined.Results In the 79 patients group,the injection dose ranged from 5 units(u)to 10 units(u),and the mean dose was 6.28±1.57 u,the duration of curative effect after the first injection ranged from 3 to 10 months,the average duration was 4.53±1.62 months.For the 12 patients group,the average injection dose from the first injection to 10 thinjection were 5.83±1.63 u、8.43±2.20 u、7.75±1.72 u,8.12±1.55 u,8.54±1.28 u,7.92±1.79 u,8.02±1.25 u,7.92±1.79 u,7.29±1.67 u,7.19±1.69 u,respectively.After the 7 th injection,the dosage declined slowly and steady and it kept between 7 to 8 units.The duration of curative effect of these 12 patients were 3 to 10 months.The average duration of the first injection was4.18±0.83 months which was the shortest.The average duration of the second time was 5.01±1.26 months,and the average duration of the third time was 4.49±0.58 months,which was shorter than the second one.From the fourth,the duration fluctuated between 4 to 6 months and it wassteady thereafter.Conclusion Type A botulinum toxin can improve the voice symptom of adductor spasmodic dysphonia markedly and the average duration of curative effect lasts for about 4 to 6 months.With the increasing of injection number,the mean dose of injection tends to be stable and it ranges from 7 to 8 units.
作者 施俊博 屈季宁 周涛 章薇 Shi Junbo;Qu Jining;Zhou Tao;Zhang Wei(Department of Otolaryngology,Head & Neck Surgery,Renming Hospital of Wuhan University,Wuhan, 430060, Chin)
出处 《听力学及言语疾病杂志》 CAS CSCD 北大核心 2018年第3期284-288,共5页 Journal of Audiology and Speech Pathology
基金 湖北省自然科学基金项目(302-132449)
关键词 痉挛性发声障碍 内收型 肉毒毒素 剂量 疗效 Spasmodic dysphonia adductor Botulinum toxin Dosage Curative effect
  • 相关文献

参考文献3

二级参考文献72

  • 1徐文,韩德民,侯丽珍,张丽,高玉红,叶京英,王军.痉挛性发音障碍诊断及治疗的研究[J].中华耳鼻咽喉头颈外科杂志,2005,40(4):253-257. 被引量:22
  • 2Shipp T, Izdebski K, Reed C, et al. Intrinsic laryngeal muscle activity in a spastic dysphonic patient[J]. J Speech Hear Dis ord, 1985, 50: 54.
  • 3Nash EA, Ludlow CL. Laryngeal muscle activity during speech breaks in adductor spasmodic dysphonia[J]. Laryngoscope, 1996, 106: 484.
  • 4Cyrus CB, Bielamowicz S, Evans FJ, et al. Adductor muscle activity abnormalities in abductor spasmodic dysphonia[J].Oto-laryngol Head Neck Surg, 2001, 124: 23.
  • 5Parnes SM, Lavorato AS, Myers EN. Study of spastic dys phonia using videofiberoptic laryngoscopy[J]. Ann Otol Rhinol Laryngol, 1978, 87:322.
  • 6Erickson ML. Effects of voicing and syntactic complexity on sign expression in adductor spasmodic dysphonia [J]. Am J Speech Lang Pathol, 2003, 12: 416.
  • 7RontalM, Rontal E, RolnickM,et al. Amethod for the treat ment oi abductor spasmodic dysphonia with botulinum toxin injections: a preliminary report[J]. Laryngoscope, 1991, 101 - 911.
  • 8Rodriquez AA, Ford CN, Bless DM, et al. Electromyographic assessment of spasmodic dysphonia patients prior to botulinum toxin injection [J]. Electromyogr Clin Neurophysiol, 1994, 34: 403.
  • 9Nutt JG, Muenter MD, Aronson A, et al. Epidemiology of focal and generalized dystonia in Rochester, Minnesota[J]. Mov Disord, 1988, 3: 188.
  • 10Stemple JC. Clinical voice pathology[M]. San Diego, Calif: Singular publishing, 2000. 119 - 127.

共引文献8

同被引文献7

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部